NCODA and Florida Cancer Specialists & Research Institute jointly announced the development of a novel oncology stakeholder education exchange program.
Cazenovia, NY, August 16, 2022 – Florida Cancer Specialists & Research Institute (FCS) jointly announced with NCODA the development of a virtual learning platform that offers focused education for governance-level Board members, disease-state experts, and generalists.
FCS will be the first to utilize this new program, with the latest updates and detailed information to be made available in real-time at the user’s convenience on NCODA’s platform, Rxchange.
Lucio Gordan, MD, FCS chief medical officer for Therapeutics and Analytics, said, “organizing the education and information exchange between providers and other health care stakeholders has been long overdue. Rxchange will greatly enhance the 2-way flow of information in an environment of rapid and unprecedented developments in cancer care and help to enhance overall patient care.“
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More